Rhiannon Barrow

Rhiannon Barrow


I graduated for the University of Liverpool in 2018 with a combined BSc and MSc which incorporated a 9 month placement in my final year with Dr Lucy Stead’s group. I remained with her group to undertake a PhD project starting in 2018 under the supervision of Dr Lucy Stead, Dr Erica Wilson, Dr James Poulter and Professor Colin Johnson. 

Glioblastoma (GBM) is the most common and aggressive form of adult brain tumour. Despite a standard treatment of surgical removal of the tumour followed by radio and chemotherapy, the average survival is still only around 12-15 months post-diagnosis. The reason for this is that populations of cells are able to survive treatment and divide to form a recurrent tumour. It is important that we look at the molecular features that define GBM cells that do not respond to treatment so that drugs can be developed to target these. My PhD project will look at a gene believed to be important in treatment resistance in GBM and how its knock-down, and the knock-down of its protein product, will affect treatment response.


  • Biological Sciences MBiolSci (Integrated Masters)